Apotheek Vanoost has a registered holding activity and consists mainly of financial fixed assets; the bankruptcy model is trained on trading and manufacturing companies and does not apply here. The 2025 annual accounts show equity of €1.04M and a net result of €92k. Equity is growing by ~9.5% per year across the filed fiscal years. Its solvency ranks better than 86% of 10331 sector peers (fiscal year 2025). The company has been active since 2008 and the Belgian State Gazette contains no insolvency or warning signals.
Checked score
Outside the general model
Holding: general score not applicable
The company has a registered holding activity and financial fixed assets account for more than half of its assets. The general operating-company model is unsuitable for this profile, so we show no financial axes either. Filed figures remain available.
Credit advice for your own amount and term
Signals
Three signals. The signal on the left, the evidence on the right.
○neutral
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 30-08-2026, 30 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 10 filingsDeviation from the deadline
2025
30 d late
2024
31 d early
2023
29 d late
2022
32 d early
2021
29 d late
2020
29 d late
2019
30 d late
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
20-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, abbreviated schema
Equity
€1.04M▼ 1.3%
2024 · €1.05M
2018: €471k
2019: €553k
2020: €740k
2021: €840k
2022: €867k
2023: €948k
2024: €1.05M
2018 → 2025
Total assets
€1.37M▲ 10.3%
2024 · €1.24M
2018: €1.18M
2019: €1.15M
2020: €1.26M
2021: €1.21M
2022: €1.18M
2023: €1.19M
2024: €1.24M
2018 → 2025
Net result
€92k▼ 23.0%
2024 · €120k
2018: €80k
2019: €81k
2020: €258k
2021: €99k
2022: €174k
2023: €99k
2024: €120k
2018 → 2025
Working capital
€200k▼ 13.3%
2024 · €230k
2018: €166k
2019: €185k
2020: €124k
2021: €226k
2022: €174k
2023: €185k
2024: €230k
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€840k-€867k▲ 3.2%€948k▲ 9.4%€1.05M▲ 11.3%€1.04M▼ 1.3%
Operating result€155k-€149k▼ 3.5%€142k▼ 5.2%€173k▲ 22.0%€128k▼ 26.0%
Net result€99k-€174k▲ 75.5%€99k▼ 43.0%€120k▲ 20.7%€92k▼ 23.0%
Turnover and EBIT margin not published: the abbreviated schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result falls in 2025; 2025 is 26% below 2024 and is the lowest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €1.37M
Fixed assets
€935k▲ 12.8%
Current assets
€438k▲ 5.4%
Equity and liabilities €1.37M
Equity
€1.04M▼ 1.3%
Debt
€332k▲ 74.9%
The debt ratio rises from 15.3% to 24.2%. Equity is lower and debt is higher.
Key figures and ratios
Solvency
75.8%▼
2024 · 84.7%
ROE
8.9%▼
2024 · 11.4%
ROA
6.7%▼
2024 · 9.6%
Debt
€332k▲
2024 · €190k
Debt ≤ 1 year
€239k▲
2024 · €186k
Debt > 1 year
€87k▲
2024 · €0
Income taxes
€33k▼
2024 · €50k
Staff costs
€67k▼
2024 · €86k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€1.24M€1.37M▲
Fixed assets21/28€829k€935k▲
Intangible fixed assets21-€1k
Tangible fixed assets22/27€9k€114k▲
Plant, machinery and equipment23€3k€2k▼
Furniture and vehicles24€6k€112k▲
Financial fixed assets28€820k€820k=
Current assets29/58€416k€438k▲
Amounts receivable after more than one year29€63k€50k▼
Other amounts receivable291€63k€50k▼
Stocks and contracts in progress3€189k€177k▼
Stocks30/36€189k€177k▼
Amounts receivable within one year40/41€3k€7k▲
Trade receivables40€3k€4k▲
Other amounts receivable41€0€3k▲
Cash at bank and in hand54/58€84k€134k▲
Deferred charges and accrued income490/1€77k€70k▼
Equity and liabilities
Total equity and liabilities10/49€1.24M€1.37M▲
Equity10/15€1.05M€1.04M▼
Contributions10/11€19k€19k=
Reserves13€1.04M€1.02M▼
Distributable reserves133€1.04M€1.02M▼
Profit (loss) carried forward14€0€0=
Amounts payable17/49€190k€332k▲
Amounts payable after more than one year17€0€87k▲
Financial debts170/4€0€87k▲
Amounts payable within one year42/48€186k€239k▲
Current portion of amounts payable after more than one year42€58k€15k▼
Trade debts44€36k€39k▲
Suppliers440/4€36k€39k▲
Taxes, remuneration and social security45€43k€37k▼
Taxes450/3€31k€34k▲
Remuneration and social security454/9€12k€3k▼
Other amounts payable47/48€48k€147k▲
Accrued charges and deferred income492/3€5k€7k▲
Income statement
Code20242025
Remuneration, social security and pensions62€86k€67k▼
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€848€4k▲
Other operating charges640/8€3k€4k▲
Gross operating margin9900€263k€203k▼
Operating profit (loss)9901€173k€128k▼
Financial income75/76B€307€279▼
Recurring financial income75€307€279▼
Financial charges65/66B€3k€3k▼
Recurring financial charges65€3k€3k▼
Profit (loss) for the period before taxes9903€170k€125k▼
Income taxes67/77€50k€33k▼
Profit (loss) for the period9904€120k€92k▼
Profit (loss) for the period to be appropriated9905€120k€92k▼
Appropriation of the result
Profit (loss) to be appropriated9906€120k€92k▼
Transfer from equity791/2€13k€106k▲
Transfer to equity691/2€120k€92k▼
To other reserves6921€120k€92k▼
Profit to be distributed694/7€13k€106k▲
Return on contributions (dividend)694€13k€106k▲
Social balance
Average headcount (FTE)90871.30.9▼
The notes to these accounts (23 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
30-08
NBB filing
Annual accounts filed
fiscal year 2025 · abbreviated schema · 30 days late
2025
30-06
NBB filing
Annual accounts filed
fiscal year 2024 · abbreviated schema
2024
31-12
Financial
Equity above €1MEq €1.05M ▲11.3%
7 profitable years in a row build equity to €1.05M.
29-08
NBB filing
Annual accounts filed
fiscal year 2023 · abbreviated schema · 29 days late
2023
29-06
NBB filing
Annual accounts filed
fiscal year 2022 · abbreviated schema
2022
29-08
NBB filing
Annual accounts filed
fiscal year 2021 · abbreviated schema · 29 days late
2021
29-08
NBB filing
Annual accounts filed
fiscal year 2020 · abbreviated schema · 29 days late
2020
31-12
Financial
Highest result since 2018net €258k ▲216%
Net result €258k, the highest in the series.
30-08
NBB filing
Annual accounts filed
fiscal year 2019 · abbreviated schema · 30 days late
2019
31-12
Financial
Equity above €500kEq €553k ▲17.3%
2 profitable years in a row build equity to €553k.
30-08
NBB filing
Annual accounts filed
fiscal year 2018 · abbreviated schema · 30 days late
2018
20-08
NBB filing
Annual accounts filed
fiscal year 2017 · abbreviated schema · 20 days late
2017
29-06
NBB filing
Annual accounts filed
fiscal year 2016 · abbreviated schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Aalst · 1 establishment unit since 2008
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Churchillsteenweg 79320 AalstGround area
1,961 m²
Building footprint
540 m²
Volume, LiDAR
5,161 m³
2 parcels, Flanders · tallest building 20.1 m, ±6 floors. Linked by address, not a title deed.
1 establishment unit
Apotheek Vanoost
since 20082.171.648.371
2 parcels
Flanders
2
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 41342B0904/00L000 | Flanders | 1,426 m² | 1 · 243 m² | - |
| 41002B0488/00L002 | Flanders | 535 m² | 1 · 297 m² | 20.1 m · 6 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1 · via establishment units: 1
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Public money · subsidies and aid
Flemish government
2023 · 1 entry · 2,000 EUR awarded · 2,000 EUR paid| Year | Entries | awarded | paid |
|---|---|---|---|
| 2023 | 1 | 2,000 EUR | 2,000 EUR |
Schemes
Hinderpremie bij openbare werken
Recognitions · licences · registrations
Food safety, FASFC
1 siteAalst2.171.648.371
Similar companies · same sector, comparable size
Pharma2Care
BE 0427.391.896
Zuienkerke · Eq €1.04M
PHARMACIE MOLITOR-MEIRLAEN
BE 0876.905.635
Viroinval · Eq €1.04M
APOTEEK SERMEUS
BE 0429.117.409
Zemst · Eq €1.04M
APOTHEEK OPSOMER
BE 0474.919.225
Poperinge · Eq €1.04M
FARMA SPRUYT
BE 0460.739.013
Kortenberg · Eq €1.04M
Of 5,222 companies in sector 47730 we hold annual accounts for 3,861. 2,982 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded18-04-2008
Fiscal year end31-12
Activities, NACEBEL
47730Retail sale of pharmaceutical products
64200Holdings
64210Activities of holding companies
Sources
Crossroads Bank for EnterprisesNational Bank · 18 filingsAddress and cadastre registers
Data from official sources, last processed on 19-09-2026. Scores and ratios are computed by Checked and are not a credit decision.